EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ribonucleicacid interference or small molecule inhibition of Runx 1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction

Tamara P Martin, Eilidh A MacDonald iD, Ashley Bradley, Holly Watson, Priyanka Saxena, Eva A Rog-Zielinska, Anmar Raheem, Simon Fisher, Ali Ali Mohamed Elbassioni, Ohood Almuzaini, Catriona Booth, Morna Campbell und 12 weitere

Cardiovascular Research · 2023

DOI: 10.1093/cvr/cvad107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Tamara P Martin und 23 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, University Pla…. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Wellcome Trust, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Myocardial infarction (MI) is a major cause of death worldwide. Effective treatments are required to improve recovery of cardiac function following MI, with the aim of improving patient outcomes and preventing progression to heart failure. The perfused but hypocontractile region bordering an infarct is functionally distinct from the remote surviving myocardium and is a determinant of adverse remodelling and cardiac contractility. Expression of the transcription factor RUNX1 is increased in the border zone 1-day after MI, suggesting potential for targeted therapeutic intervention.

Objective

This study sought to investigate whether an increase in RUNX1 in the border zone can be therapeutically targeted to preserve contractility following MI. Methods and results In this work we demonstrate that Runx1 drives reductions in cardiomyocyte contractility, calcium handling, mitochondrial density, and expression of genes important for oxidative phosphorylation. Both tamoxifen-inducible Runx1-deficient and essential co-factor common β subunit (Cbfβ)-deficient cardiomyocyte-specific mouse models demonstrated that antagonizing RUNX1 function preserves the expression of genes important for oxidative phosphorylation following MI. Antagonizing RUNX1 expression via short-hairpin RNA interference preserved contractile function following MI. Equivalent effects were obtained with a small molecule inhibitor (Ro5-3335) that reduces RUNX1 function by blocking its interaction with CBFβ.

Conclusions

Our results confirm the translational potential of RUNX1 as a novel therapeutic target in MI, with wider opportunities for use across a range of cardiac diseases where RUNX1 drives adverse cardiac remodelling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMyocardial InfarctionAnimalsMiceCore Binding Factor Alpha 2 SubunitMyocardiumMyocytes, CardiacVentricular Remodeling

Stichwörter der Autor:innen

Runx1CardiomyocytesMyocardial Infarction

Substanzen

Core Binding Factor Alpha 2 SubunitRunx1 protein, mouse

Autor:innen und Institutionen

  • British Heart Foundation Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, University Place, Glasgow G12 8TA, UK.
  • Faculty of Medicine, Institute for Experimental Cardiovascular Medicine, University Heart Centre Freiburg/Bad Krozingen, 79110 Freiburg, Germany.
  • Department of Cardiothoracic Surgery, Suez Canal University, 41522 Ismailia, Egypt.
  • School of Molecular Biosciences, University of Glasgow, Glasgow G12 8QQ, UK.
  • College of Medical, Veterinary and Life Sciences, Glasgow Polyomics, University of Glasgow, Garscube Campus, Glasgow G61 1BD, UK.
  • School of Cancer Sciences, University of Glasgow, Glasgow G12 0YN, UK.

ORCID-Profile: Eilidh A MacDonald, Lorena Zentilin, Colin Berry, Mauro Giacca, Christopher M Loughrey

Förderung

  • Cancer Research UK
  • Wellcome Trust
  • British Heart Foundation
  • British Heart Foundation Centre of Excellence
  • Newton-Mosharafa Fund
  • Beatson Institute
  • Karen Blyth
  • German Research Foundation Emmy Noether Fellow

Zitieren

APA

Martin, T. P., MacDonald, E. A., Bradley, A., Watson, H., Saxena, P., Rog-Zielinska, E. A., Raheem, A., Fisher, S., Elbassioni, A. A. M., Almuzaini, O., Booth, C., Campbell, M., Riddell, A., Herzyk, P., Blyth, K., Nixon, C., Zentilin, L., Berry, C., Braun, T., …, & Loughrey, C. M. (2023). Ribonucleicacid interference or small molecule inhibition of Runx 1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad107

Vancouver

Martin TP, MacDonald EA, Bradley A, Watson H, Saxena P, Rog-Zielinska EA, et al. Ribonucleicacid interference or small molecule inhibition of Runx 1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad107

BibTeX
@article{Martin2023,
  author = {Martin, Tamara P and MacDonald, Eilidh A and Bradley, Ashley and Watson, Holly and Saxena, Priyanka and Rog-Zielinska, Eva A and Raheem, Anmar and Fisher, Simon and Elbassioni, Ali Ali Mohamed and Almuzaini, Ohood and Booth, Catriona and Campbell, Morna and Riddell, Alexandra and Herzyk, Pawel and Blyth, Karen and Nixon, Colin and Zentilin, Lorena and Berry, Colin and Braun, Thomas and Giacca, Mauro and McBride, Martin W and Nicklin, Stuart A and Cameron, Ewan R and Loughrey, Christopher M},
  title = {Ribonucleicacid interference or small molecule inhibition of Runx 1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction},
  journal = {Cardiovascular Research},
  year = {2023},
  doi = {10.1093/cvr/cvad107}
}
Kostenlos starten →